However, hyperactivation of NRF2, due to mechanisms such as KEAP1 mutations or elevated NRF2 expression, can benefit cancer cells by protecting them from excessive oxidative stress and therapeutic agents, thereby promoting cancer cell survival (31, 32). This evidence concerns the gene KEAP1 and cancer.